ALK Inhibitor Treatment Patterns and Outcomes in Real-World Patients with ALK-Positive Non-Small-Cell Lung Cancer: A Retrospective Cohort Study is a research paper published in Targeted Oncology (2023). On theSindex it has a DataRank of 0.839. It has been cited 18 times, with 18 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.442
From this paper's citation signal
Citation Network Contribution
0.398
From 14 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 18 citers.
National Institutes of Health
Grant: 5T32GM007175-43
Pharmaceutical Sciences and Pharmacogenomics
NIGMS NIH HHS
Grant: T32 GM007175
NCI NIH HHS
Grant: T32 CA108462
NCATS NIH HHS
Grant: UL1 TR001872
National Institutes of Health
Grant: 5UL1TR001872-02
Clinical and Translational Science Institute
Genentech
FWCI
3.10
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals